WNT5A and cancer: Because Daple serves as a bona fide enhancer of the non-canonical Wnt pathway, we conclude that upregulation or downregulation in Daple expression contributes, at least in part, to the bimodal deregulation of the Wnt5a signaling pathway observed in cancers.